This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (46)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Cognitive Disorders  • Alert me on articles by topic

David A. Bennett, MD; Julie A. Schneider, MD; Robert S. Wilson, PhD; Julia L. Bienias, ScD; Steven E. Arnold, MD

Arch Neurol. 2004;61:378-384.

Objective  To test the hypothesis that the association of amyloid load with clinical Alzheimer disease (AD) and cognitive impairment is mediated through neurofibrillary tangles.

Design  Longitudinal clinicopathologic cohort study.

Participants and Setting  Forty-four individuals with clinically diagnosed AD and 53 without dementia who participated in the Religious Orders Study underwent a uniform structured clinical evaluation for AD and cognitive testing about 8 months prior to death, and brain autopsy at death.

Methods  The percent area occupied by amyloid- and the density of neurofibrillary tangles were quantified from 6 brain regions and averaged to yield summary measures of amyloid load and neurofibrillary tangles. Multivariate regression analyses were used to simultaneously examine the effects of amyloid load and neurofibrillary tangles on clinically diagnosed AD and level of cognition.

Main Outcome Measures  Clinically diagnosed AD and level of global cognitive function proximate to death.

Results  In separate logistic regression analyses, each 1% increase in amyloid load was associated with about a 50% increase in the odds of clinical AD (P = .002), and each neurofibrillary tangle was associated with a greater than 20% increase in the odds of clinical AD (P<.001). When a term for tangles was added to the regression model with amyloid, the association of amyloid load with clinical disease was reduced by more than 60% and was no longer significant, whereas the association of tangles with clinical disease was essentially unchanged. Similar results were found in analyses of global cognitive function.

Conclusion  These findings are consistent with a sequence of pathologic events whereby the effect of amyloid deposition on clinical disease is mediated by neurofibrillary tangles.

From the Rush Alzheimer's Disease Center and the Departments of Neurological Sciences (Drs Bennett, Schneider, and Wilson) and Psychology (Dr Wilson), and the Rush Institute for Healthy Aging and Department of Internal Medicine (Dr Bienias), Rush University Medical Center, Chicago, Ill; and the Center for Neurobiology and Behavior, University of Pennsylvania, Philadelphia (Dr Arnold).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Co-Localization of Amyloid Beta and Tau Pathology in Alzheimer's Disease Synaptosomes
Fein et al.
Am. J. Pathol. 2008;172:1683-1692.
ABSTRACT | FULL TEXT  

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology
Arvanitakis et al.
Neurology 2008;70:1795-1802.
ABSTRACT | FULL TEXT  

{beta}-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
Pike et al.
Brain 2007;130:2837-2844.
ABSTRACT | FULL TEXT  

Paradoxical Upregulation of Glutamatergic Presynaptic Boutons during Mild Cognitive Impairment
Bell et al.
J. Neurosci. 2007;27:10810-10817.
ABSTRACT | FULL TEXT  

Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
Berger et al.
J. Neurosci. 2007;27:3650-3662.
ABSTRACT | FULL TEXT  

The relationship between cerebral Alzheimer's disease pathology and odour identification in old age
Wilson et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:30-35.
ABSTRACT | FULL TEXT  

Chronic Distress, Age-Related Neuropathology, and Late-Life Dementia
Wilson et al.
Psychosom. Med. 2007;69:47-53.
ABSTRACT | FULL TEXT  

Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-beta Accumulation
Pierrot et al.
J. Biol. Chem. 2006;281:39907-39914.
ABSTRACT | FULL TEXT  

Diabetes is related to cerebral infarction but not to AD pathology in older persons
Arvanitakis et al.
Neurology 2006;67:1960-1965.
ABSTRACT | FULL TEXT  

Education modifies the association of amyloid but not tangles with cognitive function
Bennett et al.
Neurology 2005;65:953-955.
ABSTRACT | FULL TEXT  

Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people
Bennett et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1194-1199.
ABSTRACT | FULL TEXT  

Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz et al.
Science 2005;309:476-481.
ABSTRACT | FULL TEXT  

The Apolipoprotein E {epsilon}4 Allele Increases the Odds of Chronic Cerebral Infarction Detected at Autopsy in Older Persons
Schneider et al.
Stroke 2005;36:954-959.
ABSTRACT | FULL TEXT  

Immunization therapy for Alzheimer disease?
Bennett and Holtzman
Neurology 2005;64:10-12.
FULL TEXT